Press Registration is Now Open for the 2026 ACMG Annual Clinical Genetics Meeting

Join journalists from around the world covering the 2026 ACMG Annual Clinical Genetics Meeting in Baltimore, Maryland, March 10–14, 2026.

This annual medical and scientific conference showcases groundbreaking research and the latest advances in medical genetics, genomics, and personalized medicine. The meeting offers reporters a firsthand look at the innovations shaping the future of patient care, along with access to experts leading the field.


Why Cover the ACMG Annual Meeting?

Journalists will have opportunities to:

  • Interview leading experts in medical and laboratory genetics
  • Discover emerging trends and story ideas
  • Learn how genomics research is being integrated into everyday clinical practice
  • Explore advances in AI in genetics, gene editing, reproductive and cancer genetics, newborn screening, metabolic genetics, precision therapeutics, legal and ethical issues, and more

The meeting features diverse session formats, including Scientific Sessions, Workshops, TED-style talks, Case-Based Sessions, Platform Presentations, and Short Courses.

Abstracts will be available in January 2026 and published as a supplement to Genetics in Medicine Open.


Press Registration Instructions

Credentialed media on assignment may register at no cost.

To request the Press Registration Code and instructions, contact:
Barry Eisenberg, Communications Manager
BEisenberg@acmg.net

You will need the code to register at acmgmeeting.net.


Who Qualifies for Press Credentials

  • Reporters from print, broadcast, and online media
  • Freelancers with confirmed editorial assignments

Onsite Press Room

Location: Room 304, Baltimore Convention Center
Hours will be posted closer to the meeting.

Exhibitors may leave news releases and press kits for attending media.

Please use #ACMGMtg26 on social media; many journalists follow this hashtag for updates.


Program Highlights

  • 2026 ACMG Awards & Presidential Plenary Session — The Future of Expanded Newborn Genomic Screening
  • Non-Invasive Fetal Sequencing (NIFS) Is Coming: Are You Ready?
  • Clonal Hematopoiesis, Somatic and Post-Zygotic Mosaicism in Multigene Cancer Testing
  • Diagnostic Dilemmas from the Undiagnosed Diseases Network
  • The New Era of Genomic Oncology
  • Gene Therapy in Action: Real-World Implementation in Clinical Genetics
  • Hot Topics in Washington, DC: Impacts to Medical Genetics
  • Pre-Conference Sessions — Genetic Therapies Bootcamp; Ophthalmology & Genetics Symposium; and more

Corporate Educational Satellite Symposia

These independently supported sessions highlight new developments, innovative products, and emerging clinical insights. They are not part of the official ACMG program and are not accredited.

Below is a selection of available sessions.
View the complete list and registration links HERE.

Tuesday, March 10 | 4:00–5:30 PM

  • Transforming Patient Care in MPS II (Denali Therapeutics)
  • Unrestricted Disease Insights with Comprehensive Long-Read Sequencing (Oxford Nanopore Technologies)
  • Update on Bardet-Biedl Syndrome (BBS) Diagnostic Criteria (Rhythm Pharmaceuticals)
  • Exploring the Clinical Spectrum of Hypochondroplasia (BioMarin Pharmaceutical, Inc.)

Tuesday, March 10 | 6:15–7:45 PM

  • Achondroplasia: Importance of Early Management (BioMarin Pharmaceutical, Inc.)
  • Symposium on Thymidine Kinase 2 Deficiency (UCB)
  • Newborn Screening & Early Diagnosis for Duchenne Muscular Dystrophy (Sarepta Therapeutics, Inc.)

Wednesday, March 11 | 8:00–9:30 AM

  • Preventing Long-Term Disease Progression in Lysosomal Storage Disorders (Amicus Therapeutics)
  • Genetic Mirages: Navigating Pseudodeficiency (Sanofi)
  • Advancements in Rett Syndrome Care (Acadia Pharmaceuticals Inc.)
  • Case-Based Approaches in CTX, SLOS & ZSD (Mirum Pharmaceuticals)

ACMG Foundation Corporate Partner Insights Sessions

Wednesday, March 11 | 12:15–1:15 PM
Hear from industry leaders about emerging technologies and advances in genomic medicine.
Pre-registration required; full details will be available HERE.

Participating partners include:
• BioMarin
• Illumina Inc.
• MyOme Inc.
• Natera
• PTC Therapeutics


Day of Caring

Each year, the ACMG Foundation hosts its signature Day of Caring, a heartwarming event that brings together genetics professionals to present specially adapted bicycles to local children with genetic conditions.
For 2026, ACMG is partnering with Kennedy Krieger Institute, whose Baltimore-area families will be the recipients of these custom bicycles. This uplifting event offers a powerful, visually compelling story opportunity for attending media.
Filming and photography are permitted.


Social Media

Stay informed about meeting updates by following ACMG on on Facebook, Twitter/XInstagram, and LinkedIn.

Use #ACMGMtg26 for meeting-related posts.


Media Activities and the Press Room

ACMG does not share the media list attending or following the meeting, but we invite exhibitors to leave news releases and press kits in the onsite Press Room for the press in attendance to peruse.  We encourage exhibitors to tweet using #ACMGMtg26 as a number of media are following our Twitter feed.


Embargo Policy

All presentations, posters, abstracts, and related content are strictly embargoed until the scheduled date and time of their presentation.
News releases must state that the findings were “presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting.”


About the American College of Medical Genetics and Genomics (ACMG) and ACMG Foundation

Founded in 1991, the American College of Medical Genetics and Genomics (ACMG) is a prominent authority in the field of medical genetics and genomics and the only nationally recognized medical professional organization solely dedicated to improving health through the practice of medical genetics and genomics. The only medical specialty society in the US that represents the full spectrum of medical genetics disciplines in a single organization, the ACMG provides education, resources and a voice for more than 2,500 clinical and laboratory practice of medical genetics as well as through advocacy, education and clinical research, and to guide the safe and effective integration of genetics and genomics into all of medicine and healthcare, resulting in improved personal and public health. Genetics in Medicine and Genetics in Medicine Open, a gold open access journal, are the official ACMG journals. ACMG’s website, acmg.net, offers resources including policy statements, practice guidelines, and educational programs. The ACMG Foundation for Genetic and Genomic Medicine works to advance ACMG educational and public health programs through philanthropic gifts from corporations, foundations, and individuals.


Media Contact & Interview Requests

For interview requests with speakers, researchers, leadership, or Day of Caring families, please contact:

Judy Froehlich, MBA
Email: jfroehlich@acmg.net
Advance notice is recommended.